We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+10.28%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$3.49B
AUM Growth
+$308M
Cap. Flow
-$82.3M
Cap. Flow %
-2.36%
Top 10 Hldgs %
56.89%
Holding
645
New
145
Increased
110
Reduced
156
Closed
135
Avg Time Held Equity + Options
4.1 quarters
Top 10 Avg Time Held Equity + Options
0.5 quarters
Top 20 Avg Time Held Equity + Options
1 quarter
Avg Time Held Equity only
4.4 quarters
Top 10 Avg Time Held Equity only
0.5 quarters
Top 20 Avg Time Held Equity only
1 quarter

Top Buys

Rank Stock Value
1
JNPR icon
Juniper Networks
JNPR
+$162M
2
AXNX icon
Axonics, Inc. Common Stock
AXNX
+$128M
3
ANSS icon
Ansys
ANSS
+$119M
4
X icon
US Steel
X
+$104M
5
CTLT icon
CATALENT, INC.
CTLT
+$93.3M

Sector Composition

Rank Sector Weight
1 Energy 34.28%
2 Technology 15.43%
3 Healthcare 14.7%
4 Industrials 8%
5 Miscellaneous 7.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
BCYC icon
151
Bicycle Therapeutics
BCYC
$272M
$2.12M 0.06%
84,980
+11,379
+15% +$242K
2022 Q1
8 quarters
APCA icon
152
DELISTED
AP Acquisition Corp
APCA
$2.12M 0.06%
187,581
– –
2022 Q1
8 quarters
MCD icon
153
McDonald's
MCD
$166B
$2.11M 0.06%
+7,500
New +$2.18M
2024 Q1
0 quarters
IP icon
154
International Paper
IP
$17B
$2.1M 0.06%
53,760
-69,540
-56% -$2.52M
2023 Q4
1 quarter
PK icon
155
Park Hotels & Resorts
PK
$3.05B
$2.09M 0.06%
+119,275
New +$1.93M
2024 Q1
0 quarters
BZAI icon
156
Blaize Holdings
BZAI
$42.6M
$2.07M 0.06%
187,581
– –
2022 Q1
8 quarters
SLAM icon
157
DELISTED
Slam Corp. Class A Ordinary Share
SLAM
$2.03M 0.06%
182,628
– –
2021 Q2
11 quarters
LEGT.U
158
DELISTED
Legato Merger Corp III Units
LEGT.U
$2.03M 0.06%
+200,000
New +$2.02M
2024 Q1
0 quarters
ON icon
159
ON Semiconductor
ON
$30.2B
$2.02M 0.06%
27,500
-40,500
-60% -$3.1M
2023 Q1
4 quarters
ARCH icon
160
DELISTED
Arch Resources, Inc.
ARCH
$2.01M 0.06%
+12,500
New +$2.14M
2024 Q1
0 quarters
RARE icon
161
Ultragenyx Pharmaceutical
RARE
$1.53B
$1.99M 0.06%
42,606
-14,350
-25% -$677K
2022 Q4
5 quarters
TWLO icon
162
Twilio
TWLO
$44.5B
$1.99M 0.06%
+32,500
New +$2.14M
2024 Q1
0 quarters
NTES icon
163
NetEase
NTES
$79.6B
$1.97M 0.06%
19,058
+268
+1% +$27.4K
2023 Q4
1 quarter
ESTA icon
164
Establishment Labs
ESTA
$1.84B
$1.96M 0.06%
38,445
-10,000
-21% -$401K
2022 Q1
8 quarters
VSAC icon
165
DELISTED
Vision Sensing Acquisition Corp. Class A Common Stock
VSAC
$1.96M 0.06%
175,381
– –
2022 Q1
8 quarters
MRSN icon
166
DELISTED
Mersana Therapeutics
MRSN
$1.95M 0.06%
17,372
-4,854
-22% -$483K
2023 Q3
2 quarters
NBIX icon
167
Neurocrine Biosciences
NBIX
$14.5B
$1.93M 0.06%
14,000
-5,796
-29% -$792K
2022 Q1
8 quarters
WOLF icon
168
Wolfspeed
WOLF
$1.62B
$1.92M 0.05%
+65,000
New +$1.96M
2024 Q1
0 quarters
NLY icon
169
Annaly Capital Management
NLY
$13.8B
$1.9M 0.05%
96,500
-36,993
-28% -$713K
2022 Q4
5 quarters
KIDS icon
170
OrthoPediatrics
KIDS
$565M
$1.89M 0.05%
64,814
+24,500
+61% +$685K
2022 Q1
8 quarters
IMCR icon
171
Immunocore
IMCR
$1.51B
$1.88M 0.05%
28,924
+1,283
+5% +$88K
2022 Q1
8 quarters
ANAB icon
172
AnaptysBio
ANAB
$1.37B
$1.87M 0.05%
83,025
-4,099
-5% -$97.1K
2022 Q1
8 quarters
KNSA icon
173
Kiniksa Pharmaceuticals
KNSA
$6.22B
$1.86M 0.05%
94,495
-6,227
-6% -$122K
2022 Q3
6 quarters
XFOR icon
174
X4 Pharmaceuticals
XFOR
$289M
$1.86M 0.05%
44,517
-13,584
-23% -$378K
2023 Q2
3 quarters
IONS icon
175
Ionis Pharmaceuticals
IONS
$7.52B
$1.84M 0.05%
42,412
+13,788
+48% +$657K
2022 Q1
8 quarters

Similar funds

UBS O'Connor's Q1 2024 Portfolio in Review

As of Q1 2024, UBS O'Connor held 645 positions worth $3.49B, up 9.7% from $3.18B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

UBS O'Connor's Q1 2024 filing shows 145 new, 110 increased, 156 reduced and 135 closed positions. Its largest new stake was Juniper Networks: 4,428,704 shares worth $164M. The largest sale was Splunk Inc, an estimated $561M.

By sector, the portfolio is most concentrated in Energy at 34% of assets, up from 30% a quarter earlier, followed by Technology and Healthcare.

  • UBS O'Connor's largest Q1 2024 buy was Juniper Networks: 4,428,704 shares worth $164M.
  • UBS O'Connor added most to Axonics, Inc. Common Stock in Q1 2024, an estimated $128M increase.
  • UBS O'Connor's biggest Q1 2024 reduction was Pioneer Natural Resource Co., cutting an estimated $34M.
  • UBS O'Connor fully exited Splunk Inc in Q1 2024, selling an estimated $561M.
  • UBS O'Connor's ten largest holdings make up 57% of its $3.49B portfolio in Q1 2024.
  • UBS O'Connor opened 145 new positions and closed 135 in Q1 2024.
  • UBS O'Connor's portfolio value rose 9.7% quarter-over-quarter to $3.49B.

Based on UBS O'Connor's 13F filing for Q1 2024, filed 15 May 2024.